June 11, 2020

RESILIENT

RESILIENT Trial Published in New England Journal of Medicine

The RESILIENT study randomized stroke patients in Brazil with large vessel occlusion to mechanical thrombectomy within 8 hours of symptom onset. The trial demonstrated the efficacy of mechanical thrombectomy in the Brazilian healthcare setting. Patients were enrolled if ASPECTS ≥6 and there was no malignant collateral profile on CTA. e-ASPECTS was specified in the trial protocol for patient selection and was used prospectively in multiple trial sites.

Our Partners

Leave Your Legacy Portuguese Logo
Stryker
OSIC Logo
Boehringer Ingelheim Logo
Nvidia Logo
NCIMI Logo
GE Healthcare
Wallaby Logo
TCPDS MEMBER BLACK